Juan Cristobal Morales Muñoz/LinkedIn
Oct 10, 2026, 10:40
Juan Cristóbal Morales Muñoz: Pharmacokinetic Profiling of Factor VIII Concentrates in Chilean Patients
Juan Cristóbal Morales Muñoz, Adjunct Instructor at Pontifical Catholic University of Chile, shared a post on LinkedIn:
“The abstract of our work presented at ISTH 2026 has been published in RPTH Journal
In this series, recombinant factor VIII showed a longer half-life than plasma-derived factor VIII, although there were important differences between patients.
In patients with severe haemophilia A treated at Hospital Sótero del Río in Santiago, Chile, these findings support individual pharmacokinetic assessment with WAPPS-Hemo, particularly after switching concentrates, to better adjust doses and dosing intervals.
This work was conducted with Antonio Ibarra Quezada, Magaly Cruces Ortiz, and José Luis Lamas.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 11:32Thrombus Age Assessment Through Advanced Imaging and Biomarkers
-
Oct 10, 2026, 10:55Tzu-Fei Wang: How Should We Approach Anticoagulation for Cancer-Associated Gonadal and Renal Vein Thrombosis?
-
Oct 10, 2026, 10:50Robert Sidonio Joins ATHN Advanced Clinical Research Fellowship Program
-
Oct 10, 2026, 10:45Federica Fogacci: Co-Moderating at CA Meet 2026 in Padua – Elevating Lifestyle Interventions in Cardiology
-
Oct 10, 2026, 10:32Randall Schaefer: What Do Blood Product Wastage Rates Really Tell Us in Prehospital Care?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India